Home
Live Updates
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American ... : comparemela.com
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American ...
23ME-01473, antibody targeting ULBP6: Data will be presented on the discovery and biology of ULBP6, and the potential to restore natural killer and T cell-mediated anti-tumor immunity by targeting ULBP6
Related Keywords
United States ,
San Diego ,
California ,
American ,
,
Nasdaq ,
Securities Exchange ,
Exchange Commission ,
Clinical Research ,
Me Holding Co ,
American Association For Cancer Research ,
American Association ,
Cancer Research ,
Annual Meeting ,
Cancer Genome Atlas ,
Stage Monoclonal Antibody Targeting ,
Investor Relations ,
Drug Discovery ,
New Targets ,
Upper Level ,
San Diego Convention ,
Abstract Number ,
Poster Section ,
Board Number ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Quarterly Reports ,
Current Reports ,
Relations Contact ,
Region ,
comparemela.com © 2020. All Rights Reserved.